ADRA1B anticorps (C-Term)
Aperçu rapide pour ADRA1B anticorps (C-Term) (ABIN1731574)
Antigène
Voir toutes ADRA1B AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Reacts with human ADRA1B
-
Réactivité croisée (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins, except PLEKHG5 (45 % ).
-
Purification
- Antigen affinity purified
-
Immunogène
- Synthetic 20 amino acid peptide from C-terminus of human ADRA1B. Percent identity with other species by BLAST analysis: Human (100%), Gorilla (100%), Monkey (100%), Marmoset (100%), Mouse (100%), Rat (100%), Hamster (100%), Bovine (100%), Dog (100%)
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
Working dilution: IHC - P (11 μg/mL
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- PBS, Sodium azide 0.1 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-80 °C
-
Stockage commentaire
- Long term: -70°C, Short term: +4°C
-
-
- ADRA1B (Adrenergic, alpha-1B-, Receptor (ADRA1B))
-
Autre désignation
- ADRA1B
-
UniProt
- P35368
-
Pathways
- AMPK Signaling, Carbohydrate Homeostasis, Regulation of Carbohydrate Metabolic Process
Antigène
-